Learn more Oklo (NYSE: OKLO) is designing a small nuclear reactor that could change how we power the world. Or, at least, how artificial intelligence (AI) gets fed. Indeed, with backing from Sam ...
Vera Therapeutics recently reported a first-quarter 2026 net loss of US$121.03 million as it accelerated spending ahead of a potential U.S. commercial launch of its IgA nephropathy drug candidate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results